SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Jaguar Health CSO and Investigators Discuss Crofelemer at Dubai Conference

The company says it is targeting an NDA filing for crofelemer in microvillus inclusion disease.

JAGX

Related stories